Sort
21,281 grants matching “influenza”
Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses
$656,497Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2023 · AI
Examining the Effects of Immulina to Increase Immune Resilience against Influenza Virus Infections
$656,269Gailen D. Marshall · University Of Mississippi · U19 · FY2023 · AT
Examining the Effects of Immulina to Increase Immune Resilience against Influenza Virus Infections
$656,268Gailen D. Marshall · University Of Mississippi · U19 · FY2022 · AT
Immunology Team Contributions to the LSB
$656,183Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus
$656,068Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2009 · AI
Olfactory and neurological manifestations of acute and post-acute murine COVID-19
$656,039Stanley Perlman · University Of Iowa · R01 · FY2024 · AI
Washington National Primate Research Center
$655,914David M Anderson · University Of Washington · P51 · FY2015 · OD
Centers of Excellence for Influenza Research
$655,719National Institute Of Allergy And Infectious Diseases · Y01 · FY2010 · AI
Development of a novel highly effective influenza vaccine
$655,680Pamuk Bilsel · Flugen, Inc. · R44 · FY2019 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$655,601Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2021 · AI
Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model
$655,586Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2020 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$655,464Michael David Hughes · Harvard School Of Public Health · UM1 · FY2020 · AI
Large-scale production and purification of biological compounds
$655,324Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2010 · DK
Protein therapy to treat virus induced cardiopulmonary injury
$655,228Jianjie Ma · University Of Virginia · R01 · FY2025 · HL
Protein therapy to treat virus induced cardiopulmonary injury
$655,228Jianjie Ma · University Of Virginia · R01 · FY2023 · HL
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus
$655,156Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2011 · AI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
$655,149Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AR
Programming Durable Immune Responses To Vaccination
$654,858Ali Hassan Ellebedy · Washington University · U01 · FY2023 · AI
Epidemiology, transmission, and phylogenetics of influenza in a tropical country
$654,839Eva Harris · University Of California Berkeley · U01 · FY2010 · AI
H. influenzae: Role of Sialic Acid in Virulence
$654,676Michael A. Apicella · University Of Iowa · R01 · FY2010 · AI
Flu2Text: A Multi-Site Study assessing an Intervention for 2nd Dose of Influenza Vaccine
$654,616Melissa S Stockwell · Columbia University Health Sciences · R01 · FY2016 · HD
Discrimination of nonself by innate immune receptors
$654,379Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
New Physical Methodologies for Genomic Analysis
$654,177David C Schwartz · University Of Wisconsin-Madison · R01 · FY2012 · HG
Studies on RNAi Based Delivery in Vivo
$654,135Mark A Kay · Stanford University · R01 · FY2010 · DK
Targeting neutralizing epitopes in the MPER of HIV Env
$654,069Chinglai Yang · Emory University · R01 · FY2015 · AI